Cara Therapeutic (CARA)
$0.27 -$0.00 (-0.92%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$14.59M -
Day's Range
$0.27 - $0.28 -
Volume
460,198 -
52 Week Low / High
$0.24 - $1.31 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
CARA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 0
- Strong Buy
- 0
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- $14.29
- Target Price
Company News
-
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026 — Jan 22nd, 2024
Cara Therapeutics, Inc. – Focus on Phase 2/3 program in notalgia paresthetica (NP), a neuropathic disorder with significant unmet need – – Phase 3 program in advanced chronic kidney disease (CKD) to be discontinued – – Planned workforce reduction of up to 50% – – Cara end...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$